Cite
HARVARD Citation
Baverel, P. et al. (2019). Exposure–Response Analysis of Overall Survival for Tremelimumab in Unresectable Malignant Mesothelioma: The Confounding Effect of Disease Status. Clinical and translational science. 12 (5), pp. 450-458. [Online].